SCHEMBL649534

SCHEMBL649534

CN(C)CCCC(=O)Nc1ncc(/C=C2\SC(=Nc3ccc4cn[nH]c4c3)NC2=O)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
KMT2A Q03164 6/20 0.36
MEN1 O00255 5/20 0.36
MAPT P10636 5/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 5/20 0.36
PTPN7 P35236 3/20 0.36
DUSP3 P51452 3/20 0.36
PTPN12 Q05209 3/20 0.36
PTPN22 Q9Y2R2 3/20 0.36
PSMD14 O00487 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DYRK3 O43781 1/20 0.36
ACHE P22303 1/20 0.36
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
RAB9A P51151 2/20 0.35
P2RX7 Q99572 1/20 0.35
HCRTR1 O43613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10226352 1.00 ALDH1A1 (0.37) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL653349 0.96 ALDH1A1 (0.37) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL653350 0.96 ALDH1A1 (0.37) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL10226359 0.96 ALDH1A1 (0.37) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL10226364 0.90 ALDH1A1 (0.39) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL649005 0.90 ALDH1A1 (0.39) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL649006 0.90 ALDH1A1 (0.39) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL653810 0.89 PTPN7 (0.41) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL10227922 0.89 PTPN7 (0.41) ALDH1A1NPSR1KMT2AMEN1MAPT
SCHEMBL653809 0.89 PTPN7 (0.41) ALDH1A1NPSR1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 ALDH1A1 2165/4885NPSR1 4464/4885KMT2A 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.